Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Urges FDA To Adopt Alternatives to Broad DSCSA Enforcement Discretion
The Healthcare Distribution Alliance (HDA) urged the Food and Drug Administration (FDA) to avoid delaying certain requirements for manufacturers and repackagers to comply with the November 27, 2023, Drug Supply Chain Security Act (DSCSA) deadline, in public comments submitted to the agency.
HDA Statement on Expiration of the COVID-19 Public Health Emergency
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the expiration of the federal Public Health Emergency (PHE) for COVID-19.
HDA To Convene Rx Supply Chain Professionals as Industry Closes in on Drug Supply Chain Security Act Implementation Deadline
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar, providing an opportunity for supply chain professionals to discuss Drug Supply Chain Security Act (DSCSA) implementation.